Share:

XAG/USD fell below $22.70 and is poised for a 3.8% weekly loss.
July’s PPI from the US rose to 2.4%.
Rising yields don’t allow the metal to gain traction.

On Friday, the XAG/USD saw mild losses and will post its fourth consecutive weekly loss, having lost more than 7% since mid-July. At the end of the week, the US reported hot Producer Price Index (PPI) data and positive University of Michigan (UoM) Sentiment and inflation expectations, which fueled a rise in US bond yields.

After the release of key inflation data throughout the week, American rates are rising. The 10-year bond yield reached 4.16%, up by 1.34%. The 2-year yield stands at 4.89% with a 1% increase, while the 5-year yield is at 4.30% with 1.75 % gains. It’s worth noting that American yields tend to be negatively correlated with non-yielding precious metals, so they may limit the XAG/USD’s upside for the rest of the session.

Overall, inflation saw this week the headline and core Consumer Price Index (CPI) coming lower than expected in July, while the PPI rose to 2.4% higher than expectations. The pace for the metal and bond markets in the next session will be determined by the market’s assessments of the economic situation in the US and how it will affect the next Federal Reserve (Fed) decisions. As for now, the stronger case is that more hikes will be seen in this tightening cycle, but as Jerome Powell stated, it will all depend on the incoming data.

The technical analysis of the daily chart points to a neutral to a bearish outlook for XAG/USD, indicating the potential for further bearish movement. The Relative Strength Index (RSI) displays a flat slope below the 50 middle points, while the Moving Average Convergence (MACD) lays out weaker red bars. Furthermore, the pair is below the 20,100 and 200-day Simple Moving Averages (SMAs), highlighting the continued dominance of bears on the broader scale, requiring the buyers to take action. Traders should eye the 20 and 100-day averages as they are about to perform a bearish cross which could exacerbate the downside in the near term.

Support levels: $22.50, $22.30, $22.00.

Resistance levels: $23.25 (200-day SMA), $23.50, $23.70, $24.05 (a bearish cross between the 20 and 100-day SMA).


Share:

Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Read More